Literature DB >> 26264867

Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.

Simon Becker1,2, Jasmin Steinmeyer1, Murat Avsar3, Klaus Höffler3, Jawad Salman3, Axel Haverich2,3,4, Gregor Warnecke2,3,4, Matthias Ochs1,2,4, Anke Schnapper1,2.   

Abstract

Normothermic ex vivo lung perfusion (EVLP) has developed as a powerful technique to evaluate particularly marginal donor lungs prior to transplantation. In this study, acellular and cellular perfusate compositions were compared in an identical experimental setting as no consensus has been reached on a preferred technique yet. Porcine lungs underwent EVLP for 12 h on the basis of an acellular or a cellular perfusate composition after 24 h of cold ischaemia as defined organ stress. During perfusion, haemodynamic and respiratory parameters were monitored. After EVLP, the lung condition was assessed by light and transmission electron microscopy. Aerodynamic parameters did not show significant differences between groups and remained within the in vivo range during EVLP. Mean oxygenation indices were 491 ± 39 in the acellular group and 513 ± 53 in the cellular group. Groups only differed significantly in terms of higher pulmonary artery pressure and vascular resistance in the cellular group. Lung histology and ultrastructure were largely well preserved after prolonged EVLP and showed only minor structural alterations which were similarly present in both groups. Prolonged acellular and cellular EVLP for 12 h are both feasible with lungs prechallenged by ischaemic organ stress. Physiological and ultrastructural analysis showed no superiority of either acellular or cellular perfusate composition.
© 2015 Steunstichting ESOT.

Entities:  

Keywords:  acellular perfusion; cellular perfusion; ex vivo lung perfusion; large animal model; lung physiology; lung ultrastructure

Mesh:

Substances:

Year:  2015        PMID: 26264867     DOI: 10.1111/tri.12649

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

Review 1.  Machine perfusion of thoracic organs.

Authors:  Dirk Van Raemdonck; Filip Rega; Steffen Rex; Arne Neyrinck
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Systems engineering the organ preservation process for transplantation.

Authors:  Reinier J de Vries; Martin Yarmush; Korkut Uygun
Journal:  Curr Opin Biotechnol       Date:  2019-07-04       Impact factor: 9.740

3.  Experimental Models of Ischemic Lung Damage for the Study of Therapeutic Reconditioning During Ex Vivo Lung Perfusion.

Authors:  Roumen Parapanov; Xingyu Wang; Yabo Wang; Anne Debonneville; Jérôme Lugrin; Lucas Liaudet; Thorsten Krueger
Journal:  Transplant Direct       Date:  2022-06-10

4.  Is perfusate exchange during ex vivo lung perfusion beneficial?

Authors:  Christina C Kao; Amit D Parulekar
Journal:  Ann Transl Med       Date:  2020-02

Review 5.  Ex Vivo Lung Perfusion: Current Achievements and Future Directions.

Authors:  Nikhil K Prasad; Chetan Pasrija; Tara Talaie; Alexander S Krupnick; Yunge Zhao; Christine L Lau
Journal:  Transplantation       Date:  2021-05-01       Impact factor: 4.939

Review 6.  The pig as a model for immunology research.

Authors:  Reinhard Pabst
Journal:  Cell Tissue Res       Date:  2020-04-30       Impact factor: 5.249

7.  Cellular and acellular ex vivo lung perfusion preserve functional lung ultrastructure in a large animal model: a stereological study.

Authors:  Jasmin Steinmeyer; Simon Becker; Murat Avsar; Jawad Salman; Klaus Höffler; Axel Haverich; Gregor Warnecke; Christian Mühlfeld; Matthias Ochs; Anke Schnapper-Isl
Journal:  Respir Res       Date:  2018-12-04

8.  Multiparametric MRI for organ quality assessment in a porcine Ex-Vivo lung perfusion system.

Authors:  Julius Renne; Marcel Gutberlet; Andreas Voskrebenzev; Agilo Kern; Till Kaireit; Jan Hinrichs; Patrick Zardo; Gregor Warnecke; Marcus Krüger; Peter Braubach; Danny Jonigk; Axel Haverich; Frank Wacker; Jens Vogel-Claussen; Norman Zinne
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.